Pharma

Your Article Summary

See Latest Articles

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo in the United States
Purdue, 08/07/09

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. announced entry into an exclusive license and collaboration agreement to commercialize Intermezzo in the United States. If approved by the U.S. Food and Drug Administration, Intermezzo has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The FDA has established October 2009 as the Prescription Drug User Fee Act action date for the Intermezzo New Drug Application.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09

 See all of M&A/Partnerships